Mammography Market Size

Mammography Market Size Snapshot

Note – Market size depicts the revenue generated over the financial year

The mammography market is expected to expand at a CAGR of 9.25% between 2025 and 2034. The growth is due to the increasing awareness of the occurrence of breast cancer and the need for early detection. The emergence of mammography in the treatment of breast cancer is also facilitated by the government's efforts to improve women's health care. The use of digital and 3D tomosynthesis technology has increased the accuracy of diagnosis and the comfort of patients. Artificial intelligence is expected to increase the diagnostic accuracy of mammography systems and improve the efficiency of radiologists. Hologic, Siemens, GE and other major companies in the mammography market are investing in R & D and launching new products to capture the market. Hologic's recent advances in 3D mammography technology are an example of this ongoing innovation.

Regional Market Size

Regional Deep Dive

The mammography market is growing significantly in various regions, driven by the growing awareness of breast cancer, the technological advancements, and the government initiatives. North America has the highest penetration of digital mammography and 3D imaging, while Europe is experiencing an increase in the screening programs and regulatory support for innovations. The Asia-Pacific region is expected to emerge as a key player due to the increasing expenditure on healthcare and the rising focus on preventive care. The Middle East and Africa and Latin America are slowly but surely developing their mammography capabilities, with international collaborations and the expansion of the healthcare systems.

North America

• The U.S. Preventive Services Task Force (USPSTF) recently recommended biennial screening for women ages 50–74, which is expected to increase the screening rate and the demand for mammography services.
• Hologic and GE are leading the way in digital mammography and artificial intelligence-assisted medical images, improving diagnostic accuracy and patient outcomes.
• In the midst of the pandemic of COVID-19, the integration of telemedical services into mammography has changed the access to care and the quality of life for patients, especially in the provinces.

Europe

• The European Commission has undertaken to set up standard screening programmes for breast cancer in the member countries, to facilitate early detection and treatment.
• Siemens Healthineers is investing in new image-processing methods and artificial intelligence solutions to improve the efficiency and effectiveness of mammography.
• In Germany and France, regulatory changes have been introduced which have facilitated the approval of new mammography devices and have increased competition and market growth.

Asia-Pacific

• Japan and Australia are undertaking national breast-screening programmes, and the demand for mammography services is accordingly rising.
• The growth of private hospitals in India and China is making it possible for more women to be treated with advanced mammography equipment.
• Local governments and international organizations, such as the World Health Organization, are working together to raise awareness of the need for breast cancer screening.

MEA

• A national campaign has been launched in the United Arab Emirates to raise awareness of breast cancer among women.
• In countries like Egypt and Saudi Arabia, collaboration between local and international companies is bringing the latest mammography technology to the masses.
• The economy of the region is diversifying, and this is resulting in a greater investment in the health care system, including mammography services.

Latin America

• Brazil has set up a national screening program for breast cancer with the objective of increasing early detection and the use of mammography.
• Among the companies of the area, the companies are beginning to adopt the digital mammography, and the need for an improved diagnostic method in the cities and in the countryside is increasing.
• The governments of many countries, such as Mexico, are concentrating on increasing the budgets for health care, which should increase the availability of mammography.

Did You Know?

“During her lifetime, about one in eight women in the United States will develop breast cancer, which demonstrates the importance of regular screening.” — American Cancer Society

Segmental Market Size

The mammography market is currently growing steadily, driven by increased awareness of the importance of screening for breast cancer and by technological developments. The recommendations of the US Preventive Services Task Force on the frequency of screenings have a positive effect on the market. The technological developments, such as the introduction of digital mammography and 3D tomosynthesis, have also contributed to improved diagnostic accuracy and improved patient outcomes.

In the field of mammography, the implementation stage has reached a mature stage. Leading companies such as Hologic and Siemens Healthineers have introduced advanced systems in various hospitals. Among the main applications are screenings for breast cancer, diagnostics of symptomatic patients and research on improved detection methods. The government's emphasis on preventive medicine and its official support of screenings are important trends that are expected to accelerate growth. Artificial intelligence is also shaping the evolution of this market. By improving the analysis of images and the efficiency of clinical work, it is expected to improve the situation.

Future Outlook

The Mammography market is poised for a strong growth between 2025 and 2034, with a CAGR of 9.25%. This growth is driven by the growing prevalence of breast cancer, the increased awareness of the importance of early detection and the advancement of mammography technology. The screening rate of women eligible for mammography is expected to increase to around 75% by 2034, from the current 60 to 65%, as a result of an increased emphasis on preventive care and early diagnosis.

Artificial intelligence, the development of three-dimensional mammography, and the integration of digital images into artificial intelligence will increase diagnostic accuracy and improve patient outcomes. These developments will not only help to find breast cancer at an earlier stage, but will also reduce the number of false positives, which will improve patient trust and the compliance of screening. Furthermore, government initiatives and subsidies to improve access to mammography services, especially in underserved areas, will play an important role in increasing penetration. And as the market develops, other trends such as individualized screening and the use of telemedicine for remote consultation will also further shape the landscape and ensure that mammography will remain an important part of women's health care.